Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: part 2—functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer
Publication date:
2023
Publisher version:
Citación:
Supportive Care in Cancer, 31(3), (2023); doi:10.1007/s00520-023-07617-6
ISSN:
Patrocinado por:
This work was supported by grants from Division of Cancer Prevention, National Cancer Institute (R01CA238946-02).
Collections
- Artículos [37532]